Transesophageal Echocardiography to Identify pAtients With Low Risk of Stroke in Atrial Fibrillation - TIARA Pilot Study (TIARA)
Atrial Fibrillation, Stroke
About this trial
This is an interventional treatment trial for Atrial Fibrillation focused on measuring Echocardiography
Eligibility Criteria
Inclusion Criteria: Documented atrial fibrillation or atrial flutter, paroxysmal or permanent Conventional indication for VKA treatment Signed informed consent Exclusion Criteria: Planned electro cardioversion Very high risk of TE (previous ischemic stroke or systemic TE, symptoms of heart failure or left ventricular dysfunction, mitral valve stenosis, hypertrophic cardiomyopathy) Indication for VKA treatment other than atrial fibrillation (e.g. mechanic valve prosthesis) Atrial fibrillation secondary to reversible diseases (e.g. thyrotoxicosis) Contraindication for treatment with VKA, aspirin, or clopidogrel
Sites / Locations
- Twenteborg
- VUMC
- Rijnstate Ziekenhuis
- Amphia Ziekenhuis
- Jeroen Bosch Ziekenhuis
- Atrium Medisch Centrum Heerlen
- Academisch Ziekenhuis Maastricht
- Diaconessenhuis Meppel
- UMCN
- Viecuri
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
Aspirin
Coumarin derivates
Ascal 100mg once daily
Acenocoumarol or fenprocoumon